| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +12% |
| 3Y CAGR | +13% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +16% |
| 3Y CAGR | -24% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,845.00 +124.50 (4.58%) | 21,608.60 | 31.87 | 6.03 | ||
PfizerPFIZER | ₹4,643.70 +16.10 (0.35%) | 21,256.23 | 28.91 | 5.06 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,940.50 +72.50 (1.06%) | 17,367.38 | 102.39 | 19.9 | ||
Natco PharmaNATCOPHARM | ₹838.30 -4.95 (0.59%) | 15,010.30 | 13.11 | 1.63 |